FDA Approves New Pfizer Pneumococcal Vaccine for Adults

FDA Approves New Pfizer Pneumococcal Vaccine for Adults

A new pneumococcal 20-valent conjugate vaccine by Pfizer, PREVNAR 20™, has been approved for adults by the FDA in efforts to strengthen the prevention of disease and pneumonia caused by 20 Streptococcus pneumoniae (pneumococcus) serotypes. The authorized vaccine not...
Europe Runs Low on Pneumonia Vaccine as Demand Grows

Europe Runs Low on Pneumonia Vaccine as Demand Grows

With the spike in COVID-19 cases worldwide, there is an increasing amount of people who are seeking precautionary vaccines for respiratory issues in preparation for the winter. Merck’s Pneumovax 23, more specifically, has hit record high sale volumes worldwide in the...